Flinton Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $554K | Hold |
1,664
| – | – | 0.02% | 427 |
|
|
2019
Q2 | $520K | Hold |
1,664
| – | – | 0.02% | 463 |
|
|
2019
Q1 | $509K | Sell |
1,664
-320
| -16% | -$97.9K | 0.02% | 458 |
|
|
2018
Q4 | $461K | Sell |
1,984
-80
| -4% | -$18.6K | 0.02% | 443 |
|
|
2018
Q3 | $646K | Buy |
2,064
+704
| +52% | +$220K | 0.02% | 419 |
|
|
2018
Q2 | $392K | Hold |
1,360
| – | – | 0.01% | 482 |
|
|
2018
Q1 | $340K | Hold |
1,360
| – | – | 0.01% | 516 |
|
|
2017
Q4 | $325K | Buy |
1,360
+128
| +10% | +$30.6K | 0.01% | 539 |
|
|
2017
Q3 | $274K | Buy |
1,232
+144
| +13% | +$32K | 0.01% | 537 |
|
|
2017
Q2 | $246K | Buy |
1,088
+448
| +70% | +$101K | 0.01% | 528 |
|
|
2017
Q1 | $128K | Buy |
640
+96
| +18% | +$19.2K | ﹤0.01% | 579 |
|
|
2016
Q4 | $99K | Buy |
+544
| New | +$99K | ﹤0.01% | 596 |
|